CN107513059A - A kind of 23 azacyclo- Thiochromone compounds of substitution and its synthetic method and the application in antifungal drug - Google Patents
A kind of 23 azacyclo- Thiochromone compounds of substitution and its synthetic method and the application in antifungal drug Download PDFInfo
- Publication number
- CN107513059A CN107513059A CN201610450799.3A CN201610450799A CN107513059A CN 107513059 A CN107513059 A CN 107513059A CN 201610450799 A CN201610450799 A CN 201610450799A CN 107513059 A CN107513059 A CN 107513059A
- Authority
- CN
- China
- Prior art keywords
- compound
- hydrogen
- alkyl
- thiochromone
- azacyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000006467 substitution reaction Methods 0.000 title claims abstract description 20
- 238000010189 synthetic method Methods 0.000 title claims description 12
- 239000003429 antifungal agent Substances 0.000 title abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 38
- -1 oxyl Chemical group 0.000 claims abstract description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 20
- 239000001257 hydrogen Substances 0.000 claims abstract description 19
- 239000000460 chlorine Substances 0.000 claims abstract description 9
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 9
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract description 6
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims abstract description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 6
- 239000011737 fluorine Substances 0.000 claims abstract description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 5
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims abstract description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 3
- 239000011630 iodine Substances 0.000 claims abstract description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000000047 product Substances 0.000 claims description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 230000000844 anti-bacterial effect Effects 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 238000003786 synthesis reaction Methods 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000003899 bactericide agent Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical group O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 239000012752 auxiliary agent Substances 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical class CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 claims description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 2
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 claims description 2
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical class CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 claims description 2
- MOFINMJRLYEONQ-UHFFFAOYSA-N [N].C=1C=CNC=1 Chemical group [N].C=1C=CNC=1 MOFINMJRLYEONQ-UHFFFAOYSA-N 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 2
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 150000004777 chromones Chemical class 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- USSBDBZGEDUBHE-UHFFFAOYSA-L magnesium;2-oxidooxycarbonylbenzoate Chemical compound [Mg+2].[O-]OC(=O)C1=CC=CC=C1C([O-])=O USSBDBZGEDUBHE-UHFFFAOYSA-L 0.000 claims description 2
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- XCRBXWCUXJNEFX-UHFFFAOYSA-N peroxybenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1 XCRBXWCUXJNEFX-UHFFFAOYSA-N 0.000 claims description 2
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 claims description 2
- 239000012286 potassium permanganate Substances 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 238000007363 ring formation reaction Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000012265 solid product Substances 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- HGNVEXMJZVUWJO-UHFFFAOYSA-N 3-methylhexan-3-amine Chemical compound CCCC(C)(N)CC HGNVEXMJZVUWJO-UHFFFAOYSA-N 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052738 indium Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 229910001950 potassium oxide Inorganic materials 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 abstract description 7
- 206010017533 Fungal infection Diseases 0.000 abstract description 6
- 238000001228 spectrum Methods 0.000 abstract description 4
- 241000233866 Fungi Species 0.000 abstract description 3
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 14
- 239000003814 drug Substances 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000000843 anti-fungal effect Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- RIKMMFOAQPJVMX-UHFFFAOYSA-N fomepizole Chemical compound CC=1C=NNC=1 RIKMMFOAQPJVMX-UHFFFAOYSA-N 0.000 description 5
- 229960004285 fomepizole Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- YCDMZJGTEZGKPM-UHFFFAOYSA-N O1C=CC(C2=CC=CC=C12)=S.[Cl] Chemical class O1C=CC(C2=CC=CC=C12)=S.[Cl] YCDMZJGTEZGKPM-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 230000001857 anti-mycotic effect Effects 0.000 description 3
- 239000002543 antimycotic Substances 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- FLGZHHJNRZUPIL-UHFFFAOYSA-N chromene-4-thione Chemical compound C1=CC=C2C(=S)C=COC2=C1 FLGZHHJNRZUPIL-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 241000222173 Candida parapsilosis Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 241000222126 [Candida] glabrata Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 208000032343 candida glabrata infection Diseases 0.000 description 2
- 229940055022 candida parapsilosis Drugs 0.000 description 2
- OTAFHZMPRISVEM-UHFFFAOYSA-N chromone Chemical compound C1=CC=C2C(=O)C=COC2=C1 OTAFHZMPRISVEM-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 1
- 0 CCSC(Sc1c(*)c(*)c(*)c(*)c11)=C(*)C1=O Chemical compound CCSC(Sc1c(*)c(*)c(*)c(*)c11)=C(*)C1=O 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000228150 Penicillium chrysogenum Species 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241001149962 Sporothrix Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 241001480050 Trichophyton violaceum Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- HYJODZUSLXOFNC-UHFFFAOYSA-N [S].[Cl] Chemical compound [S].[Cl] HYJODZUSLXOFNC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- RIVIDPPYRINTTH-UHFFFAOYSA-N n-ethylpropan-2-amine Chemical compound CCNC(C)C RIVIDPPYRINTTH-UHFFFAOYSA-N 0.000 description 1
- 230000009707 neogenesis Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940055035 trichophyton verrucosum Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
The present invention relates to one kind 2 to substitute 3 azacyclo- Thiochromone compounds to have following structure:Wherein R2It is hydrogen, oxyl, hydrocarbon amino, C1‑C3The penta azacyclo of alkyl substitution;R3It is the five yuan of nitrogenous heteroaromatics substituted by hydrogen, methyl, nitro or cyano group;R4、R5、R7It is independently selected from hydrogen, fluorine, chlorine, bromine or iodine;R6Selected from hydrogen, fluorine, chlorine, bromine, iodine, C1‑C6Oxyl, C1‑C6Hydrocarbon amino, phenoxy group, by one or more C1‑C6Alkyl or C1‑C6The phenoxy group of oxyl substitution.The compound of the present invention, which has, prepares antifungal drug purposes, all has stronger bacteriostatic activity to common causative fungi and deep fungal infection, and toxicity is low, stability is good, anti-fungus spectra is wide.
Description
Technical field
The present invention relates to a kind of antimycotic 2- substitutions -3- azacyclo-s Thiochromone compound and its synthetic method and its
Prepare the application in antifungal drug.
Background technology
In recent years, widely using due to broad-spectrum antibiotic, immunodepressant and all kinds of hormone medicines, and putting
The reasons such as treatment, organ transplant and infected by HIV cause human immune system's function reduction, and the probability for causing body fungal infection increases
Add, so as to cause the morbidity and mortality of fungal diseases constantly to rise.Drug resistance present in other clinical treatment and anti-
The problems such as bacterium spectrum is narrow, also increase the treatment difficulty of fungal infection class disease.Therefore develop wide spectrum, efficiently, low toxicity it is new
Antifungal drug, it has been the sciences problems for being badly in need of solving.
Activity research shows that Thiochromone compound has obvious antifungal activity, at present the thiochromone of document report
Class compound, more with synthesis obtain based on.Early in 1976, Hiroyuki NakazuMi et al. just reported the sulphur of its synthesis
Chromone compounds;Square woods in 1998 et al. is in its document, it was recently reported that 6,7 halos and 1 thioether bond are oxidized to sulfone
The synthesis of sulphur color (full) ketone and its antifungal activity;1998, Yu Xinrui et al. described 3- benzyl -6- chlorine in its document
The synthesis of thiochromanone and antifungal activity;2007, Huang Wei et al. designed a series of thiochromone class for having synthesized 2 sulfur-bearings
Compound, describe seven kinds of mycologic tests such as external anti-Fusarium oxysporum and show bacteriostatic activity, 2009, Xiao Tao et al. was in thiochromone
2 introducing sulfenyls of class compound, describe such compound to common causative fungi and deep fungal infection with stronger
Antibacterial and antifungal activity etc..
Chromone and Thiochromone compound, because of the special chemical constitution and bioactivity that it has, the world is caused
The extensive concern of upper medicine researcher.Either natural extract or synthetic product, antibacterial new target spot and mechanism of action are
Through as research direction important at present.Recent decades, with computer aided molecular design technology, bioactivity screening skill
The application of the new technologies such as art, molecular biology, genomics and ripe day by day, the research and development for greatly accelerating antifungal drug are entered
Degree.It is contemplated that deepening continuously with research, has more efficient, low toxicities, the antifungal drug of wide spectrum is developed and made
Good fortune is in the mankind.
The content of the invention
It is an object of the present invention to provide a kind of 2- substitutions -3- azacyclo-s Thiochromone compound and its synthetic method and anti-true
Application in bacterium and antibacterial medicines.
2- substitution -3- azacyclo- Thiochromone compounds involved in the present invention, its chemical constitution are as follows:
R3One kind in five yuan of nitrogen azoles rings of such as formula (II):
Wherein:J, K, L are separately selected from hydrogen, C1-C3Alkyl;
R2Selected from hydrogen,- O-Z or C1-C3Alkyl-substituted penta azacyclo;
Wherein, Y is selected from hydrogen;C1-C6Alkyl;Benzyl;Containing in trifluoromethyl, trifluoromethoxy, nitro, halogen, cyano group
Five yuan or hexa-atomic aromatic ring of one or more substituents;
Y ' is selected from hydrogen;C1-C6Alkyl;
Z is selected from hydrogen;C1-C6Alkyl;Benzyl;Containing one in trifluoromethyl, trifluoromethoxy, nitro, halogen, cyano group
Or five yuan or hexa-atomic aromatic ring of multiple substituents;
R4、R5、R7Separately selected from hydrogen, fluorine, chlorine, bromine or iodine;
R6Selected from hydrogen, fluorine, chlorine, bromine, iodine, C1-C6Oxyl, C1-C6Hydrocarbon amino, C1-C6Alkyl, phenoxy group, by 1
Individual or multiple C1-C6The phenoxy group of oxyl substitution;
The synthetic method of formula (I) compound, it is that compound (III) is dissolved in organic solvent, is reacted with carbon disulfide, warp
Condensation, after cyclization with C1-C6Halohydrocarbons reaction generation compound (V), oxidized dose of compound (V) oxidation generation compound
(VI), then under the conditions of alkali compounds and R2H reacts, and obtains solid product 2- substitution -3- azacyclo- thiochromone class chemical combination
Thing;
The structural formula of the compound (III) is as follows:
The structural formula of the compound (V) is as follows:
The structural formula of the compound (VI) is as follows:
Wherein, X represents F or Cl;
R2、R3、R4、R5、R6、R7The same formula of definition (I);
R8Selected from C1-C6Alkyl;
The organic solvent be selected from DMF, DMA, dimethyl sulfoxide, dioxane,
At least one of acetonitrile, tetrahydrofuran, methanol, ethanol, isopropanol, tert-butyl alcohol.It is preferred that DMF, diformazan are sub-
Sulfone.
The oxidant is selected from manganese dioxide, potassium permanganate, potassium bichromate, hydrogen peroxide, benzoyl hydroperoxide, m-chloro peroxide
At least one of benzoic acid, magnesium monoperoxyphthalate or Peracetic acid.It is preferred that hydrogen peroxide, metachloroperbenzoic acid.
The alkali compounds is selected from alkali carbonate, alkali metal hydroxide, alkali metal acetate or triethylamine, two
In ethyl isopropylamine, N- methyl piperidines, N-ethylpiperidine, N-methylmorpholine, N-ethylmorpholine, pyridine, 4- picolines extremely
Few one kind.It is preferred that sodium hydroxide, potassium hydroxide, potassium carbonate, cesium carbonate.
The reaction can use each step product to be directly entered the one-step synthesis of reaction in next step without isolation or incite somebody to action
Often walk reaction product isolated and purified after enter in next step reaction step synthesis.
The synthetic method of the present invention is a kind of universal method, is suitable for synthesizing thiochromone compound and its derivative, to virtue
A variety of functional groups on ring have high tolerance, therefore in fact to the substituent in Thiochromone compound and its derivative
There is no particular restriction for number and species.
Formula (I) compound of the present invention also includes its salt allowed on pharmaceutics.
The present invention provides the 2- substitutions -3- azacyclo-s Thiochromone compound and is preparing the people for the treatment of fungal infection disease
With the application in medicine or medicine for animal.
In the medicine in addition to containing active component 2- substitution -3- azacyclo- Thiochromone compounds, also contain and medicine
Upper acceptable carrier, auxiliary agent and/or diluent, form composition.
The formulation of the medicine is solution, creme, suppository, paste or solution.
The present invention also provides the 2- substitutions -3- azacyclo-s Thiochromone compound and answered as agriculture and horticultural bactericides
With.
In the bactericide in addition to containing active component 2- substitution -3- azacyclo- Thiochromone compounds, also contain and medicine
Acceptable carrier, auxiliary agent and/or diluent on thing, form composition.
By determining minimum inhibitory concentration MIC (i.e. compound can suppress to test the concentration of microorganism growth), to the present invention
The antifungal activity of 2- substitution -3- azacyclo- Thiochromone compounds has carried out in-vitro evaluation.Experiment confirms that 2- of the present invention takes
Generation -3- azacyclo- Thiochromone compounds have broad-spectrum antifungal activity, internal in human body and animal (particularly mammal)
It with pharmacological activity, can mix with the acceptable diluent or carrier of common chemotherapy, or with other excipient, be made molten
The formulations such as liquid, creme, suppository, ointment, solution, partial smearing use is carried out in the form of medicine, is had for fungal infection disease
The effect of obvious.Except for preparing antimycotic people's use or animal antifungal beyond the region of objective existence, 2- substitutions -3- azacyclo-s of the present invention
Thiochromone compound can be also used for agricultural and gardening bactericide, to various phytopathogen disease such as rice blast,
Barley and the powder mildew of wheat and the powder mildew of other various host plants (such as cucumber, apple, grape), the rust of wheat, swallow
The hat rust of wheat and the rust of other various hosts, the preventing and treating that the pathogenicities of the late blight of tomato and other host plants is rotted etc.
It is highly effective.
Embodiment
The synthetic method of the present invention is illustrated below by specific embodiment.It should be noted that given here retouch
The embodiment just for the sake of the description present invention with embodiment is stated, technical staff is easier to understand the present invention, they
It is not intended to limit the scope of the present invention.
Embodiment 1, the synthetically prepared reaction equation of Formula V 1 are as follows:
Preparation process is as follows:
1- (2,4- bis- chloro- 5- fluorophenyls) -2- (4-methylpyrazole -1- bases) ethyl ketone 18.4mmol is added in single-necked flask,
DMSO30mL, NaOH 43mmol, 40 DEG C are warming up under stirring, CS is added dropwise at this temperature222.8mmol 5mL DMSO's is molten
Liquid.Drop finishes, 40 DEG C of stirring reactions of temperature control.Reaction is finished, and is cooled to room temperature, and iodoethane 25.6mmol 10mL DMSO solutions are added dropwise,
Drop finishes, and room temperature reaction to reaction is finished, and reaction solution is stirred down and poured into 50mL frozen water, has a large amount of solids to separate out, and is collected by filtration solid
Body, recrystallize in ethanol, obtain the fluoro- 7 chlorine thiochromones of formula (V1) product 2- ethylmercapto groups -3- (4-methylpyrazole -1- bases) -6- --
14.0mmol, yield 76%.
1H NMR (300MHz, DMSO) δ=8.48 (d, 1H), 8.16 (d, 1H), 7.54 (d, 2H), 3.26 (q, 2H),
2.12 (s, 3H), 1.33 (t, 3H)
2~embodiment of embodiment 7:The preparation of formula (V) Thiochromone compound
Using (III) compound as raw material, preparing product formula (V) compound, (target product is formula (V2)~(V7) in table 1
Each compound), for preparation process with embodiment 1, reaction equation is as follows:
In 2~embodiment of embodiment 7, each group selection of product formula (V) Thiochromone compound and preparation reagent and inspection
Survey data and be listed in table 1.
Embodiment 8:The synthetically prepared reaction equation of Formula IV 1 is as follows:
Preparation process is as follows:
Into 100mL single-necked flasks, the fluoro- 7 chlorine thiochromones of 2- ethylmercapto groups -3- (4-methylpyrazole -1- bases) -6- are sequentially added
10mmol, acetic acid 20mL, 65 DEG C are heated to, 30% H is added dropwise2O212mmol stirring reactions 6 hours, add sodium sulfite extraction and go out,
It is evaporated under reduced pressure and removes solvent acetic acid, is then extracted with 50mL dichloromethane and 50mL water, take dichloromethane layer, be washed twice with water
(50mL × 2), organic layer is reclaimed, is evaporated under reduced pressure to formula (VI1) product 2- second sulfinyls -3- (4-methylpyrazole -1- bases) -6-
Fluoro- 7 chlorine thiochromone 8.9mmol, yield 89%.
1H NMR (500MHz, DMSO) δ 8.69 (d, 1H), 8.24 (d, 1H), 7.97 (s, 1H), 7.64 (s, 1H), 3.67-
3.69 (m, 1H), 2.76-2.79 (m, 1H), 2.14 (s, 3H), 1.25-1.31 (m, 3H)
9~embodiment of embodiment 14:The preparation of formula (VI) Thiochromone compound
Respectively using (V2~V7) compound as raw material, preparing product formula (VI2~VI7) compound, (preparation process is the same as implementation
Example 8, reaction equation is as follows:
In 9~embodiment of embodiment 14, each group selection of product formula (VI2~VI7) Thiochromone compound and preparation are used
Reagent and detection data are listed in table 2.
Table 2
Embodiment 15:The synthetically prepared reaction of formula (I1) is as follows:
Preparation process is as follows:
Into 100mL single-necked flasks, the fluoro- 7 chlorine sulphur of 2- second sulfinyls -3- (4-methylpyrazole -1- bases) -6- is sequentially added
Chromone 1mmol, K2CO32.5mmol and 5mL DMF, under room temperature condition, magnetic agitation is opened, weighs 1.5mmol diformazan aqueous amine
Solution, it is slowly dropped at room temperature in reaction solution.Question response is finished, and is extracted with 20mL dichloromethane and 20mL water, takes dichloromethane
Layer, is washed twice with water (20mL × 2), and recovery organic layer is evaporated under reduced pressure, and obtains formula (I1) product 2- dimethylamino -3- (4- methyl
Pyrazol-1-yl) the fluoro- 7 chlorine thiochromone 0.82mmol of -6-, yield 82%.
1HNMR (500MHz, DMSO) δ 8.25 (d, 1H), 8.03 (d, 1H), 7.53 (s, 1H), 7.45 (s, 1H), 2.83
(s, 6H), 2.11 (s, 3H)
16~embodiment of embodiment 23:The preparation of formula (I) Thiochromone compound
Respectively using (VI) compound as raw material, prepare product formula (I) compound (target product be table 1 in formula (I2)~
(I9) each compound), for preparation process with embodiment 15, reaction equation is as follows:
In 16~embodiment of embodiment 23, the selection of each group of product formula (I) Thiochromone compound and preparations reagent with
Detection data are listed in table 3.
Table 3
Embodiment 24:Extracorporeal antifungal activity is tested
1st, experiment bacterial strain
Candida parapsilosis, sporothrix, saccharomyces cerevisiae Aspergillus, Candida albicans, Candida glabrata, tropical beads
Bacterium, Trichophyton rubrum, Penicillium notatum, Trichophyton verrucosum, Trichophyton violaceum, neogenesis cryptococcus, gram Rou Shi candida albicans, Epidermophvton tinea
Bacterium, trichophyton gypseum.
2nd, reagent and material
Experiment material:
Improve Martin's culture medium, 96 well culture plates, DMSO
Control drug:Fluconazole
3rd, experimental method
(1) preparation of antibacterial decoction
Test medicine is dissolved with DMSO respectively, 25.6g/L solution is made into, is saved backup in less than -20 DEG C.Before experiment
The tested decoction of deepfreeze is taken out, melted in 35 DEG C of insulating boxs, it is standby with 10 times of RPMI1640 dilutions.
(2) preparation of inoculation liquid
The tested beads bacterial strain of brother (Candida parapsilosis, Candida albicans, Candida glabrata, Candida tropicalis) is in improvement horse
Transferred species on fourth culture medium, suspension is made with the Sterile Saline that mass fraction is 0.85% in it.Spore is counted with blood cell counting plate
Son, bacteria containing amount is adjusted, it is 1 × 10 to make colony forming unit6~5 × 106CFU/mL.During inoculation with RPMI-1640 nutrient solutions by its
After 200 times of dilution, then 10 times are diluted, CFU values are adjusted to 0.5 × 103~6.0 × 103CFU/mL, it is standby.
(3) prepared by MIC plates
Under sterile working, add the μ L of RPMI-1640 nutrient solutions 100 in No. 1 hole of 96 hole polyethylene boards of sterilizing, as sky
White control.No. 2 hole adds the μ L of bacterium solution 190, and 3-12 holes add the μ L of bacterium solution 100 configured.Then 10 μ L are added in No. 2 holes
Tested decoction, by the concentration in 10 grades of doubling dilution 2-11 holes, the ultimate density for making each hole is 128,64,32,16,8,4,2,1,
0.5,0.25mg/L, No. 12 hole is not added with tested decoction as growth control.35 DEG C of normal airs are placed in after each MIC plates are closed to incubate
In case, full 24h judged results are incubated.
(4) result judges
The OD values in each hole are surveyed in 620nm with enzyme micro-plate reader, the least concentration for declining more than 80% using OD values is used as MIC
Value.> 128mg/L are calculated as when MIC value is higher than 128mg/L;≤ 0.25mg/L is calculated as when MIC value is less than 0.25mg/L.
(5) repeated observation and statistics
Above-mentioned experiment needs at least in triplicate, when occurring that MIC value is single to jump hole, is then recorded as the suppression bacterium of maximum
Concentration, when two or more, which occurs, in MIC value jumps hole, then re-start experiment.
4th, antimycotic sensitivity tests result
Determined and found by preliminary MIC, test-compound has broad-spectrum antifungal activity, wherein embodiment (15)~reality
It is more notable to apply the Thiochromone compound suppression fungi activity of example (24), 10mg/ is respectively less than to the MIC value of above strain subject
L。
Claims (8)
- It is 1. a kind of as the 2- substitution -3- azacyclo- Thiochromone compounds of formula (I), its chemical constitution are as follows:R3One kind in five yuan of nitrogen azoles rings of such as formula (II):Wherein:J, K, L are separately selected from hydrogen, C1-C3Alkyl;R2Selected from hydrogen,- O-Z or C1-C3Alkyl-substituted penta azacyclo;Wherein, Y is selected from hydrogen;C1-C6Alkyl;Benzyl;Containing one in trifluoromethyl, trifluoromethoxy, nitro, halogen, cyano group Or five yuan or hexa-atomic aromatic ring of multiple substituents;Y ' is selected from hydrogen;C1-C6Alkyl;Z is selected from hydrogen;C1-C6Alkyl;Benzyl;Containing one in trifluoromethyl, trifluoromethoxy, nitro, halogen, cyano group or more Five yuan or hexa-atomic aromatic ring of individual substituent;R4、R5、R7Separately selected from hydrogen, fluorine, chlorine, bromine or iodine;R6Selected from hydrogen, fluorine, chlorine, bromine, iodine, C1-C6Oxyl, C1-C6Hydrocarbon amino, C1-C6Alkyl, phenoxy group, by 1 or Multiple C1-C6The phenoxy group of oxyl substitution.
- 2. compound according to claim 1, its feature compound includes its salt allowed on galenic pharmacy.
- 3. a kind of synthetic method of the formula of claim 1 (I) compound, it is characterized in that, compound (III) is dissolved in organic solvent In, reacted with carbon disulfide, through condensation, after cyclization with C1-C6Halohydrocarbons reaction generation compound (V), compound (V) is through oxygen Agent oxidation generation compound (VI), then reacted under the conditions of alkali compounds with R2H, obtain solid product 2- substitutions -3- Azacyclo- Thiochromone compound;The structural formula of the compound (III) is as follows:The structural formula of the compound (V) is as follows:The structural formula of the compound (VI) is as follows:Wherein, X represents F or Cl;R2、R3、R4、R5、R6、R7The same formula of definition (I);R8Selected from C1-C6Alkyl.
- 4. synthetic method according to claim 3, it is characterized in that the organic solvent is selected from DMF, N, In N- dimethyl acetamides, dimethyl sulfoxide, dioxane, acetonitrile, tetrahydrofuran, methanol, ethanol, isopropanol, the tert-butyl alcohol extremely Few one kind;The oxidant is selected from manganese dioxide, potassium permanganate, potassium bichromate, hydrogen peroxide, benzoyl hydroperoxide, m-chloro peroxide At least one of benzoic acid, magnesium monoperoxyphthalate or Peracetic acid;The alkali compounds is selected from alkali metal carbonic acid Salt, alkali metal hydroxide, alkali metal acetate or triethylamine, diethylisopropylamide, N- methyl piperidines, N-ethylpiperidine, N- Methyl morpholine, N-ethylmorpholine,;At least one of pyridine, 4- picolines.
- 5. according to the synthetic method described in claim 3,4, it is characterized in that the organic solvent be selected from DMF, Dimethyl sulfoxide;The oxidant is selected from hydrogen peroxide, metachloroperbenzoic acid;The alkali compounds is selected from sodium hydroxide, hydrogen Potassium oxide, potassium carbonate, cesium carbonate.
- 6. according to the synthetic method described in claim 3-5, it is characterized in that often step reaction product is directly entered without isolation The one-step synthesis of reaction or enter the substep of reaction in next step after the product that every step is reacted is isolated and purified in next step Synthetic method.
- 7. 2- substitutions -3- azacyclo-s Thiochromone compound described in a kind of claim 1 is answered as agriculture and horticultural bactericides With.
- 8. application according to claim 7, contain active component 2- substitution -3- azepines it is characterized in that being removed in the bactericide Outside epithio chromone compounds, also containing pharmaceutically acceptable carrier, auxiliary agent and/or diluent, composition is formed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610450799.3A CN107513059A (en) | 2016-06-17 | 2016-06-17 | A kind of 23 azacyclo- Thiochromone compounds of substitution and its synthetic method and the application in antifungal drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610450799.3A CN107513059A (en) | 2016-06-17 | 2016-06-17 | A kind of 23 azacyclo- Thiochromone compounds of substitution and its synthetic method and the application in antifungal drug |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107513059A true CN107513059A (en) | 2017-12-26 |
Family
ID=60721569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610450799.3A Pending CN107513059A (en) | 2016-06-17 | 2016-06-17 | A kind of 23 azacyclo- Thiochromone compounds of substitution and its synthetic method and the application in antifungal drug |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107513059A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109280051A (en) * | 2018-09-20 | 2019-01-29 | 南京工业大学 | A kind of preparation of chromone compounds and its application in dye-sensitized solar cells |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1147514A (en) * | 1996-06-14 | 1997-04-16 | 沈阳药科大学 | Thiochrome ketones as antifungal agent |
CN1246118A (en) * | 1997-01-28 | 2000-03-01 | 大塚化学株式会社 | Chromone derivatives and bactericidal and herbicidal agent containing the same as active ingredient |
CN101519402A (en) * | 2009-04-13 | 2009-09-02 | 南京工业大学 | Thiochromone compound, synthetic method and application thereof in preparing antifungal medicaments |
-
2016
- 2016-06-17 CN CN201610450799.3A patent/CN107513059A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1147514A (en) * | 1996-06-14 | 1997-04-16 | 沈阳药科大学 | Thiochrome ketones as antifungal agent |
CN1246118A (en) * | 1997-01-28 | 2000-03-01 | 大塚化学株式会社 | Chromone derivatives and bactericidal and herbicidal agent containing the same as active ingredient |
CN101519402A (en) * | 2009-04-13 | 2009-09-02 | 南京工业大学 | Thiochromone compound, synthetic method and application thereof in preparing antifungal medicaments |
Non-Patent Citations (1)
Title |
---|
J. R. BANTICK,等: "Synthesis of 2-Aminochromones. Studies on the Nucleophilic Displacement of Sulphinyl and Sulphonyl Groups in the 2-Position of 5,8-Dimethoxychromone", 《J. HETEROCYCLIC CHEM.》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109280051A (en) * | 2018-09-20 | 2019-01-29 | 南京工业大学 | A kind of preparation of chromone compounds and its application in dye-sensitized solar cells |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3380478B1 (en) | Ester acc inhibitors and uses thereof | |
EP2994128B1 (en) | Acc inhibitors and uses thereof | |
JP6417401B2 (en) | ACC inhibitors and uses thereof | |
US10208063B2 (en) | ACC inhibitors and uses thereof | |
US10208044B2 (en) | ACC inhibitors and uses thereof | |
CA3004796A1 (en) | Pyrazole acc inhibitors and uses thereof | |
IE55233B1 (en) | Triazole antifungal agents | |
CN115160248A (en) | Method for producing Kakeromycin and derivatives thereof | |
CN107513059A (en) | A kind of 23 azacyclo- Thiochromone compounds of substitution and its synthetic method and the application in antifungal drug | |
CN107118204A (en) | A kind of 3- azacyclo-s Thiochromone compound and its synthetic method and the application in antifungal drug | |
CN107556296A (en) | A kind of 2- hydroxyls -3- azacyclo-s chromone compounds and its synthetic method and the application in antifungal drug | |
UA110102C2 (en) | 8-HYDROXYCHINOLINE-7-CARBOXAMIDE SECONDARY DERIVATIVES FOR THEIR APPLICATION AS ANTI-FUNCTIONAL PRODUCTS | |
CN109485607B (en) | Beta-azole-phenyl ketone derivative and application thereof | |
CN103819464B (en) | Sulphur chroman compound and synthetic method thereof and prepare the application of antifungal drug | |
KR20120097407A (en) | New secondary 8-hydroxyquinoline-7-carboxamide derivatives | |
CN107151242B (en) | 2-azolothiochromone compound, synthesis method thereof and application thereof in preparation of antifungal drugs | |
SK116198A3 (en) | Azole compounds endowed with antimycotic activity for human and veterinary use | |
CN113616641A (en) | Application of 3-phenylindole derivative in preparation of antifungal drugs | |
CN112645940A (en) | 1,3, 4-oxadiazole-norfloxacin heterozygote and preparation method and application thereof | |
CN103724271A (en) | Substituted imidazole-1-ethylene compound and application thereof | |
CN108003133A (en) | A kind of 2- hydroxyls -6- fluorine Thiochromone compound and its synthetic method and the application in weeding |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171226 |
|
WD01 | Invention patent application deemed withdrawn after publication |